This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Journal: Behavioral Brain Research 228:87-90 (2012)
Authors: L Krause, P.G Enticott, A Zangen, P.B Fitzgerlad
Neuroimaging studies suggest that the medial prefrontal cortex (mPFC) plays a central role in cognitive theory of mind (ToM).
To assess more definitively, using deep transcranial magnetic stimulation (dTMS), whether the mPFC plays a central role in ToM.
Sixteen healthy participants (10 females, 6 males) completed tasks assessing cognitive and affective ToM following low-frequency dTMS to bilateral mPFC in active-stimulation and placebo-stimulation sessions.
There was no effect of dTMS on either cognitive or affective ToM performance. When examining self-reported empathy, however, there was evidence for a double dissociation: dTMS disrupted affective ToM performance for those with high self-reported empathy, but improved affective ToM performance for those with low self-reported empathy.
mPFC appears to play a role in affective ToM processing, but this study suggests that stimulation outcomes are dependent on baseline empathic abilities.